Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancerDavid Avigan, Donald Küfe, Zhiyou Wu et al.|Bone Marrow Transplantation|2000Cited by 32
A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)Robin Joyce, David Avigan, Meredith M. Regan et al.|Annals of Oncology|2003Cited by 13
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell TransplantationJacalyn Rosenblatt, David Avigan, Irit Avivi et al.|Transplantation and Cellular Therapy|2013Cited by 7
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell TransplantationJacalyn Rosenblatt, David Avigan, Nikhil C. Munshi et al.|Blood|2012Cited by 7
Dendritic Cell Tumor Fusion Vaccination in Conjunction with Autologous Transplantation for Multiple Myeloma.Jacalyn Rosenblatt, David Avigan, Irit Avivi et al.|Blood|2009Cited by 6